Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, has a significant potential in promoting muscle building by enhancing insulin effects on muscle cells. This multifaceted approach starts from its ability to optimize...